We report acute encephalopathy associated with infl uenza A infection in 3 adults. We detected high cerebrospinal fl uid (CSF) and plasma concentrations of CXCL8/IL-8 and CCL2/MCP-1 (CSF/plasma ratios >3), and interleukin-6, CXCL10/IP-10, but no evidence of viral neuroinvasion. Patients recovered without sequelae. Hyperactivated cytokine response may play a role in pathogenesis.
by nasopharnygeal aspirate/IFA; patient 1 did not receive antiviral treatment. Both patients recovered in the next 2 days. Patient 3 had fever, severe chronic obstructive pulmonary disease exacerbation requiring noninvasive ventilatory support, complicated by acute coronary syndrome. He was given oseltamivir, 75 mg 2×/day, after infl uenza A infection was confi rmed. Agitation and confusion developed in the patient on day 3-4 of illness (onset after the third dose of oseltamivir), despite resolution of the patient's respiratory failure. These symptoms were followed by involuntary, tremulous movements involving all 4 limbs, while at rest and during movement. Brain CT scan was normal. Electroencephalogram showed generalized slowing. Oseltamivir was stopped after the ninth dose, but tremor persisted. CSF analyses showed no pathogen or pleocytosis. The patient's symptoms resolved in the next 3-4 days without sequelae.
Despite apparently normal CSF fi ndings, high concentrations of cytokines/chemokines were detected in the CSF and plasma specimens of all patients ( Table 2 ). Plasma concentrations of IL-6, CXCL8/IL-8, CXCL10/IP-10, CCL2/ MCP-1, and CXCL9/MIG were elevated at median values of 2.0, 2.8, 11.9, 3.7, and 2.1× the upper limits of their re-spective reference ranges (comparable to or higher than that observed in other hospitalized infl uenza patients) (Table 2) (7) . Other cytokines were not elevated (4, 7) . In their CSF, IL-6, CXCL8/IL-8, CXCL10/IP-10, and CCL2/MCP-1 were consistently detected, and were elevated at median values of 2.6, 15.0, 3.4, and 20.0 × the upper limits of their respective plasma reference ranges. The CSF/plasma concentration ratios of CXCL8/IL-8 and CCL2/MCP-1 were >3 (median CSF/plasma ratio 5.4 and 8.0, respectively).
Simultaneous CSF and plasma OC and OP concentrations were determined for patient 3, as symptoms progressed at 18 h after oseltamivir. The concentrations (mean ± SD) of OC in duplicate CSF and plasma samples were 18.3 ± 0.9 ng/mL and 143.8 ± 3.3 ng/mL, respectively; the CSF/plasma concentration ratio was 12%-13%. The OP plasma concentration was 1.05 ± 0.03 ng/mL; it was not detectable in the CSF.
Conclusions
We report 3 adults with acute encephalopathy (altered consciousness, confusion) associated with infl uenza. High CSF and blood cytokine/chemokine (CXCL8/IL-8, CCL2/ MCP-1, IL-6, CXCL10/IP-10) levels were detected. No ev- In all cases, there was no hypoglycemia, and liver and renal function test results were normal. C-reactive protein level was elevated in all cases. For patient 3, an electroencephalogram was performed and showed generalized slowing of background consistent with moderate encephalopathic change (similar to that observed in septic encephalopathy) (1, 6) . Findings are consistent with previous reports on adult cases of influenza-associated encephalopathy: patients are all unvaccinated, pleocytosis and cerebral imaging abnormalities (even with magnetic resonance imaging) are usually absent, and symptoms are generally self-limiting (1, 6) . Most reports have mentioned influenza A as a cause of encephalopathy, and more commonly subtype H3N2 (1-6).
idence of direct viral neuroinvasion was found. All patients recovered rapidly without sequelae (1, 6) . Our fi ndings agree with studies of infl uenza-associated encephalopathy in children. Infl uenza virus is rarely detected in the CSF, and pleocytosis is often absent (1, 2, (4) (5) (6) . High levels of cytokines (e.g., IL-6, soluble tumor necrosis factor receptor 1) can be consistently found in CSF/blood specimens, correlating with disease severity and outcomes (hyperactivated cytokine response is absent in febrile seizure associated with infl uenza) (2) (3) (4) 8) . We found a broader range of cytokines/chemokines being activated (7); for certain cytokines (CXCL8/IL-8, CCL2/MCP-1), the CSF concentrations were 3× those in plasma. IL-6, CXCL8/ IL-8, CCL2/MCP-1 and CXCL10/IP-10 have been shown to play pathogenic roles in CNS viral infections, cerebral injury, and acute brain syndrome in susceptible patients (7, 9, 10, 12) . The high CSF/plasma ratios suggest that for some cytokines, activation within the CNS might have occurred along with respiratory-tract and systemic productions (cytokines are not detected in CSF normally; (Table 2) (4,7-10,12). Resident macrophages/monocytes, astrocytes, microglial and endothelial cells in the CNS are shown to release cytokines/chemokines when stimulated by viral/ infl uenza infection; activation mechanisms without involving overt CNS invasion have been suggested (1, 4, 9, (12) (13) (14) . Cytokines may cause direct neurotoxic effects, cerebral metabolism changes, or breakdown of the blood-brain-barrier (endothelial injury) to produce symptoms (1) (2) (3) (4) 8, (12) (13) (14) .
Whether early viral suppression by antivirals can lead to attenuation of these cytokine responses and better outcomes warrants further study (7) .
We measured oseltamivir concentrations because of the concerns over its neuropsychiatric side-effects in children and adolescents. However, only the active metabolite (OC) was detected in the CSF of patient 3; the CSF/plasma concentration ratio was 12%-13% (18.3/143.8 ng/mL) at 18-hours postdose. This degree of CSF penetration is similar to that observed among healthy patients, with a Cmax CSF/plasma concentration ratio of 3.5% (at ≈8 hours), and a ratio of ≈10% at 18 hours (concentration-time profi les for plasma/CSF differ). Assuming a similar ratio, the CSF OP concentration would have fallen below the assay's detection limit (0.25 ng/mL) by 18 hours (11, 15) . The low CSF drug-penetration, together with high cytokines in CSF and symptom progression despite drug withdrawal suggest that the manifestations of patient 3 may have been diseaserelated. Symptoms developed in patients 1 and 2 without antiviral exposure. Further investigations on the CNS effects of oseltamivir in the clinical setting are needed..
Our study is limited by the small patient number and the lack of feasibility in obtaining CSF for study/comparison in infl uenza patients without neurologic symptoms. Further studies on the clinical spectrum of infl uenza encephalopathy and encephalitis in adults (1, 6) and their pathogenesis are indicated. In conclusion, acute encephalopathy may occur in adults with infl uenza. Exuberant 3) pg/mL, respectively. In CSF, in subjects without neurologic disease/infection, these cytokines/chemokines are either undetectable or present at low levels (8) (9) (10) . In a pediatrics influenza cohort, CSF cytokine levels were substantially higher in encephalopathy cases when compared to those with febrile seizure; CSF/plasma concentration was <1 (8) . †CSF cytokine concentrations above plasma reference ranges. ‡CSF/plasma cytokine concentration ratio consistently >3 (3.5-12.1), in addition to CSF cytokine concentrations being above the plasma reference ranges. For IFN-, IL-12p70, TNF-, IL-10, IL-1 and RANTES, because of their low/undetectable levels, the CSF/plasma ratios were not calculated. CSF specimens from patients 1 and 2 were collected at the peak of symptoms, and before antiviral treatment (if given); CSF from patient 3 was collected when persistent tremor developed 18 hours after the ninth dose of oseltamivir; the drug was stopped afterward. cytokine/chemokine response may play an important role in its pathogenesis.
Acute Encephalopathy Associated with Influenza A Infection in Adults
Technical Appendix
Methods on Virus Detection and the Measurements of Cytokine and Oseltamivir Concentrations Section I. Methods of Virus Detection
Influenza viral RNA was detected using H1/H3 subtype-specific primers (1,2) (H1:
5-TGA GGG AGC AAT TGA GTT CA-3 and 5-TGC CTC AAA TAT TAT TGT GT-3; H3: 5-GCA ACT GTT ACC CTT ATG AT-3 and 5-TCA TTG TTT GGC ATA GTC AC-3). After RNA extraction, a 10-µL aliquot of the extracted preparation was mixed with 15 µL of reverse transcription-PCR (RT-PCR) master mix, which containing 12.5 µL of 2× reaction mix, 0.5 µL of SuperScript III RT/ Platinum Taq Mix (Invitrogen, Carlsbad, CA, USA), 5 pmole of each forward and reverse primer, and adjusted to a volume of 15 µL with nuclease-free distilled water. For influenza A H1, the reaction condition was 30 min at 45°C for reverse transcription followed by 2 min at 94°C, and 30 cycles of 1 min at 94°C, 1 min at 52°C and 1 min at 68°C; and a final extension of 10 min at 68°C. The reaction condition for influenza A H3 was similar, except that reverse transcription was carried out at 50°C and the annealing temperature was 55°C. The PCR products were separated by gel electrophoresis and visualized by SYBR safe DNA stain 
Section 3. Measurement of Oseltamivir Concentration
Oseltamivir concentration assays were performed by the Clinical Pharmacology Laboratory in the Faculty of Tropical Medicine, Bangkok, by using tandem mass spectrometry (7) . respectively. The performance of the assay was demonstrated by analysis of 3 replicates of quality control samples at 3 levels. The coefficients of variation (CV%) during the analysis of OP were 4.1%,1.9% and 2.1% at 3 ng/mL, 20 ng/mL, and 150 ng/mL, respectively (limit of detection of OP, 0.25 ng/mL). The coefficients of variation (CV%) during the analysis of OC were 2.3%, 0.5%, and 3.1% at 30 ng/mL, 400 ng/mL, and 4,000 ng/mL, respectively.
